Pharmarise Holdings Corporation

Tokyo Stock Exchange 2796.T

Pharmarise Holdings Corporation Price to Earnings Ratio (P/E) on February 07, 2025: -16.24

Pharmarise Holdings Corporation Price to Earnings Ratio (P/E) is -16.24 on February 07, 2025, a -176.37% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Pharmarise Holdings Corporation 52-week high Price to Earnings Ratio (P/E) is 21.52 on March 21, 2024, which is 232.48% above the current Price to Earnings Ratio (P/E).
Pharmarise Holdings Corporation 52-week low Price to Earnings Ratio (P/E) is -22.42 on October 01, 2024, which is -38.00% below the current Price to Earnings Ratio (P/E).
Pharmarise Holdings Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is -7.65.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Tokyo Stock Exchange: 2796.T

Pharmarise Holdings Corporation

CEO	Mr. Masayuki Akiyama
IPO Date	Feb. 21, 2007
Location	Japan
Headquarters	Sumitomo Nakano Sakue Building
Employees	1,848
Sector	Healthcare
Industries Drugstores & Retail Pharmacies

Description

Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years